StockNews.com Initiates Coverage on TRACON Pharmaceuticals (NASDAQ:TCON)

StockNews.com started coverage on shares of TRACON Pharmaceuticals ( NASDAQ:TCON – Free Report ) in a research note released on Monday. The brokerage issued a hold rating on the biopharmaceutical company’s stock.

TRACON Pharmaceuticals Stock Performance NASDAQ TCON opened at $0.03 on Monday. The company has a market capitalization of $109,802.



00, a PE ratio of 0.01 and a beta of 1.37.

TRACON Pharmaceuticals has a 52-week low of $0.00 and a 52-week high of $14.75.

The company has a 50-day simple moving average of $0.04 and a 200 day simple moving average of $0.32.

About TRACON Pharmaceuticals ( Get Free Report ) Featured Stories Receive News & Ratings for TRACON Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TRACON Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter ..